Clinical Trial Update: Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating conditioning with fludarabine and busulfan followed by allogeneic stem cell transplantation in older adults with acute myeloid leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Adult Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-04-28